None listed
Conditions
Interventions
Procedure/Surgery : Ropivacaine injection (7.5 mg/mL) is used in this study. A volume of ropivacaine solution calculated as 0.4 mL per kilogram of body weight is mixed with 0.2 mL of epinephrine, and
Sponsors
Samsung Medical Center
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: ? Patients undergoing breast reconstruction using an abdominal flap ? Individuals who are capable of making independent decisions and communicating effectively. ? Female patients aged 19 years or older who have received sufficient explanation of the study and have provided written informed consent to participate.
Exclusion criteria
Exclusion criteria: ? Patients who have undergone breast reconstruction using autologous tissue from sites other than the abdomen. ? Patients younger than 19 years of age. ? Patients with severe heart failure. ? Patients with active bleeding (including intracranial hemorrhage, gastrointestinal bleeding, hemoptysis) or those in a state of shock. ? Pregnant women or women with suspected pregnancy. ? Patients with known hypersensitivity or a history of allergic reactions to this drug or other amide-type local anesthetics. ? Patients aged 70 years or older for whom voluntary informed consent is considered difficult to obtain. ? Patients with inflammation at or around the injection site. ? Patients with sepsis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean postoperative abdominal pain score measured using the visual analog scale (VAS) during the hospital stay | — |
Secondary
| Measure | Time frame |
|---|---|
| Total opioid consumption during the hospital stay (morphine equivalent dose, MME) | — |
Countries
Korea, Republic of
Contacts
Public ContactWoo KyungJae
Samsung Medical Center
Outcome results
None listed